Europe — EMA
Afqlir (Aflibercept)
Afqlir is a pharmaceutical product containing Aflibercept, used for intravitreal administration. It is manufactured by Sandoz GmbH and is intended for specific
Request sourcing
What is Aflibercept?
Afqlir is a pharmaceutical product containing Aflibercept, used for intravitreal administration. It is manufactured by Sandoz GmbH and is intended for specific eye conditions. Learn more about its uses and effects.
What is Aflibercept used for?
Afqlir, containing Aflibercept, is primarily used for intravitreal administration to address certain eye conditions. This medication is designed to target specific issues within the eye, providing a targeted approach to treatment. Understanding what Aflibercept is used for can help patients and healthcare providers make informed decisions about its application.
What are the side effects of Aflibercept?
Afqlir may cause common effects such as redness, itching, or discomfort in the eye. These effects are generally mild and temporary. Patients should monitor their symptoms and consult their healthcare provider if they experience persistent or severe reactions.
What precautions apply to Aflibercept?
When handling Afqlir, it is important to follow proper hygiene practices to prevent contamination. This medication should only be administered by a qualified healthcare professional. Patients should inform their healthcare provider about any allergies or medical conditions before using Aflibercept.
What does Aflibercept interact with?
Afqlir may interact with other medications, particularly those that affect the eyes. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Aflibercept.



